ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) announced today that Steven R. Hagen, Ph.D. has been promoted to vice president of pharmaceutical development and manufacturing, reporting to AMRI Chairman, President and CEO Thomas E. D’Ambra, Ph.D.
